InsiderTrades

Hoch Lynelle

SEC CIK 2005382 · EDGAR

Companies

TickerCompanyTitleHoldingBoughtSoldTradesFirstLast
BMYBristol Myers SquibbPres, Cell Therapy Org 12.2K — — 92024-03-102026-03-10

Most active insiders at BMY, 12 months

#InsiderTitleBoughtSold
1 Elkins David VEVP, CFO —$1.85M
2 Massacesi CristianEVP, Chief Med Offr, Head of Dev —$403.5K
3 Holzer Phil MSVP, Ctrl —$33.8K
4 Short Bartie WendyEVP, Corp. Affairs ——
5 Hoch LynellePres, Cell Therapy Org ——
6 Poole Ahn AmandaEVP, CHRO ——
7 Gallman CariEVP, GC ——
8 Lenkowsky AdamEVP, Chief Commercial Off ——
9 Shanahan KarinEVP, Chief Supply Chain, Ops ——
10 Meyers Gregory ScottEVP, Chief Digital, Tech Off ——

Transactions 9

Type
Reset
X Filed Traded Ticker Company Insider Title Type Price Qty Owned ΔOwn Value
DM 2026-03-12 2026-03-10 BMY Bristol Myers Squibb Hoch Lynelle Pres, Cell Therapy Org M - OptEx $0.00 +8,192 12.2K +204% $0
DM 2026-03-12 2026-03-10 BMY Bristol Myers Squibb Hoch Lynelle Pres, Cell Therapy Org J - Other $0.00 -3,302 9,122 -27% $0
DM 2026-03-12 2026-03-10 BMY Bristol Myers Squibb Hoch Lynelle Pres, Cell Therapy Org F - Tax $60.13 -1,391 5,913 -19% -$83.6K
DM 2025-03-12 2025-03-10 BMY Bristol Myers Squibb Hoch Lynelle Pres, Cell Therapy Org M - OptEx $0.00 +7,446 7,920 +1,571% $0
DM 2025-03-12 2025-03-10 BMY Bristol Myers Squibb Hoch Lynelle Pres, Cell Therapy Org J - Other $0.00 -2,213 6,070 -27% $0
DM 2025-03-12 2025-03-10 BMY Bristol Myers Squibb Hoch Lynelle Pres, Cell Therapy Org F - Tax $63.11 -2,248 4,711 -32% -$141.9K
DM 2024-03-12 2024-03-10 BMY Bristol Myers Squibb Hoch Lynelle Pres, Cell Therapy Org J - Other $0.00 -1,317 707 -65% $0
DM 2024-03-12 2024-03-10 BMY Bristol Myers Squibb Hoch Lynelle Pres, Cell Therapy Org F - Tax $53.79 -1,308 257 -84% -$70.4K
DM 2024-03-12 2024-03-10 BMY Bristol Myers Squibb Hoch Lynelle Pres, Cell Therapy Org M - OptEx $0.00 +4,351 801 New $0

Purchase Sale Sale after option exercise All abbreviations